These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7528778)

  • 1. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.
    Puré E; Camp RL; Peritt D; Panettieri RA; Lazaar AL; Nayak S
    J Exp Med; 1995 Jan; 181(1):55-62. PubMed ID: 7528778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
    Uff CR; Neame SJ; Isacke CM
    Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
    Lokeshwar VB; Fregien N; Bourguignon LY
    J Cell Biol; 1994 Aug; 126(4):1099-109. PubMed ID: 7519619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.
    Lesley J; English N; Perschl A; Gregoroff J; Hyman R
    J Exp Med; 1995 Aug; 182(2):431-7. PubMed ID: 7543138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
    Katoh S; Zheng Z; Oritani K; Shimozato T; Kincade PW
    J Exp Med; 1995 Aug; 182(2):419-29. PubMed ID: 7543137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
    Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
    J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
    Dougherty GJ; Cooper DL; Memory JF; Chiu RK
    J Biol Chem; 1994 Mar; 269(12):9074-8. PubMed ID: 7510702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.
    He Q; Lesley J; Hyman R; Ishihara K; Kincade PW
    J Cell Biol; 1992 Dec; 119(6):1711-9. PubMed ID: 1469058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44-hyaluronate interaction mediates in vitro lymphocyte binding to the white matter of the central nervous system.
    Aho R; Jalkanen S; Kalimo H
    J Neuropathol Exp Neurol; 1994 May; 53(3):295-302. PubMed ID: 7513749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type.
    van der Voort R; Manten-Horst E; Smit L; Ostermann E; van den Berg F; Pals ST
    Biochem Biophys Res Commun; 1995 Sep; 214(1):137-44. PubMed ID: 7545390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion.
    Siegelman MH; Stanescu D; Estess P
    J Clin Invest; 2000 Mar; 105(5):683-91. PubMed ID: 10712440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
    Yang B; Yang BL; Savani RC; Turley EA
    EMBO J; 1994 Jan; 13(2):286-96. PubMed ID: 7508860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
    Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
    J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition.
    Zheng Z; Katoh S; He Q; Oritani K; Miyake K; Lesley J; Hyman R; Hamik A; Parkhouse RM; Farr AG; Kincade PW
    J Cell Biol; 1995 Jul; 130(2):485-95. PubMed ID: 7542251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response.
    Lesley J; Howes N; Perschl A; Hyman R
    J Exp Med; 1994 Jul; 180(1):383-7. PubMed ID: 7516415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate.
    Wu L; Kincade PW; Shortman K
    Immunol Lett; 1993 Sep; 38(1):69-75. PubMed ID: 7507884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.